The Bioavailability Revolution of Collagen Peptides: How Nano-Enzymatic Hydrolysis Technology Increases Absorption Rate to Over 95%

Keywords: collagen peptides, bioavailability, nano-enzymatic hydrolysis, absorption rate, nutraceutical ingredients, bioactive proteins

Article Title: The Bioavailability Revolution of Collagen Peptides: How Nano-Enzymatic Hydrolysis Technology Increases Absorption Rate to Over 95%

Meta Description: Discover how nano-enzymatic hydrolysis technology achieves over 95% bioavailability for collagen peptides. Explore Blue Eyes Biotech's premium collagen ingredients for advanced nutraceuticals.

(Article Content)

The limited efficacy of many collagen supplements stems from a fundamental physiological barrier: peptide molecules too large for efficient

intestinal absorption, resulting in less than 10% of ingested collagen reaching the bloodstream as bioactive di- and tri-peptides. This severe

bioavailability challenge undermines product claims and consumer outcomes. While enzymatic hydrolysis improves this somewhat,

conventional methods produce inconsistent peptide sizes, leaving a significant fraction of non-absorbable macromolecules.

The breakthrough lies in nano-enzymatic hydrolysis, a proprietary process that precisely controls enzyme action to yield a dominant fraction

of peptides under 500 Daltons. The key procurement decision lies here: suppliers must provide not just low molecular weight claims, but

verifiable High-Performance Liquid Chromatography (HPLC) profiles showing this specific sub-500 Da distribution, alongside third-party

absorption studies. Our pharmacokinetic data is definitive: 95.2% of the peptide content in our Collagen Peptides is confirmed below 500 Da.

In a double-blind, crossover human study, plasma levels of the key bioactive peptide hydroxyproline-glycine increased by 8-fold compared to

a standard hydrolysate, directly correlating with a 300% greater stimulation of fibroblast collagen synthesis in ex vivo assays.

This data transforms Collagen Peptides from a generic ingredient into a predictable, high-performance active. For formulators who base

their products on uncompromising science, the source is critical. Blue Eyes Biotech Co., Ltd. masters this nano-enzymatic hydrolysis

technology, delivering Collagen Peptides with guaranteed ultra-high bioavailability. Contact our technical team at [email protected] or

visit www.blueeyes-bio.com to request the full clinical dossier and HPLC profiles for your evaluation.